IL2 triggers a tumor progression process in a melanoma cell line MELP, derived from a patient whose metastasis increased in size during IL2/INFα biotherapy

Oncogene

Volumn 12, Issue 5, 1996, Pages 1015-1023

  Han, Daishu ^a   Pottin Clemenceau, Corinne ^a   Imro, Maria Adele ^b   Scudeletti, Marco ^b   Doucet, Christelle ^a   Puppo, Franco ^b   Brouty Boye, Daniele ^a   Vedrenne, Jocelyn ^a   Sahraoui, Yasmina ^a   Brailly, Hervé ^c   Poggi, Alessandro ^d   Jasmin, Claude ^a   Azzarone, Bruno ^a   Indiveri, Franco ^b  

^a HÔPITAL PAUL BROUSSE   (France)

^b UNIVERSITY OF GENOA   (Italy)

^c Immunotech   (France)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

Human melanomas; IL 2R; Tumor progression

Indexed keywords

ALPHA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HERMES ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; HUMAN; HUMAN CELL; MELANOMA; METASTASIS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TUMOR GROWTH;

ADULT; ANIMALS; ANTIGENS, CD44; ANTIGENS, NEOPLASM; CELL DIVISION; CYTOKINES; DISEASE PROGRESSION; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-2; INTERLEUKIN-6; MALE; MELANOMA; MICE; MICE, NUDE; RECEPTORS, INTERLEUKIN-2; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 9244225622     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Alileche A, Plaisance S, Han DS, Rubinstein E, Mingari C, Bellomo R, Jasmin C and Azzarone B. (1993). Oncogene, 8, 1791-1796.
2. Altomonte M, Colizzi F, Esposito G and Maio M. (1992). N. Eng. J. Med., 327, 959.
3. Benveniste EN and Merrill JE. (1986). Nature, 321, 610-613.
4. Birch M, Mitchell S and Hart IR. (1991). Cancer Res., 51, 6660-6667.
5. Bosco MC, Espinoza-Delgado I, Schwabe M, Gusella GL, Longo DL, Sugamura K and Varesio L. (1994). Blood, 83, 2995-3002.
6. Buckle AM and Hogg N. (1992). E. J. Immunol, 20, 337-342.
7. Burton JD, Bamford RN, Peters C, Kurys G, Goldman CK, Brennan J, Roessler E and Waldmann TA. (1994). Proc. Natl. Acad. Sci USA, 91, 4935-4939.
8. Chomcynski P and Sacchi N. (1987). Analytical Biochem., 162, 156-159.
9. Frasier-Scott K, Hatzakis H, Seong D, Jones CM and Wu KK. (1988). J. Clin. Invest., 82, 1877-1883.
10. Giri JG, Ahdieh M, Eisenman J, Shanebeck K, Grabstein K, Kumaki S, Namen A, Park LS, Cosman D and Anderson D. (1994). EMBO J., 13, 2822-2830.
11. Green JE, Beyley CG, Wagner DK, Waldmann TA and Jay G. (1989). Mol. Cell. Biol., 9, 4731-4737.
12. Herlyn M. (1990). Clin. Exp. Metast., 8, 9.
13. Johnson JP, Stade BG, Holzmall B, Schwable W and Riethmuller G. (1989). Proc. Natl. Acad. Sci. USA, 86, 641-644.
14. Kanakura Y, Sugahara H, Mitsui H, Ikeda H, Furitsu T, Yagura H, Kitayama H, Kanayama Y and Matsuzawa Y. (1993). Cancer Res., 53, 675-680.
15. Lu C and Kerbel RS. (1993). J. Cell. Biol., 120, 1281-1288.
16. Lu C, Vickers MF and Kerbel RS. (1992). Proc. Natl. Acad. Sci. USA, 89, 9215-9219.
17. Morimoto K, Robin E, Lebousse-Kerdiles, MC, LY Y, Clay D, Jasmin C and Smadja-Joffe F. (1994). Blood, 87, 657-662.
18. Noguchi M, Yi H, Rosenblatt HM, Flipovitch AH, Adelstein S, Modi WS, McBride OW and Leonard WL. (1993). Cell, 73, 147-157.
19. Obiri NI, Debinski W, Leonard WJ and Puri RK. (1995). J. Biol. Chem., 270, 8797-8804.
20. Plaisance S, Rubinstein E, Alileche A, Han DS, Sahraoui Y, Mingari M, Bellomo R, Rimoldi D, Colombo M, Jasmin C, Carrel S and Azzarone B. (1993). Int. J. Cancer, 55, 164-170.
21. Plaisance S, Rubinstein E, Alileche A, Benoit P, Jasmin C and Azzarone B. (1993). Int. Immunol., 5, 843-848.
22. Plaisance S, Rubinstein E, Elileche A, Krief P, Augery-Bourget Y, Sahraoui Y, Jasmin C, Suarez H and Azzarone B. (1992). Int. Immunol., 4, 739-746.
23. Rimoldi D, Salvi S, Hartmann F, Scheyer M, Blum S, Zogafros L, Plaisance S, Azzarone B and Carrel S. (1993). Anticancer Res., 13, 555-564.
24. Rosemberg SA, Lotze MT, Muul LM, Chang AE, Avis FP, Leitman S, Linhean WM, Robertson CN, Lee RE, Rubin JT, Seipp CA, Simpson CG and White DE. (1987). N. Eng. J. Med., 316, 889-897.
25. Rosemberg SA, Lotze MT, Yang JC, Aebersold PM, Linhean WM, Seipp CA and White DE. (1989). Ann. Surg, 210, 474-484.
26. Russel S, Keegan AD, Harada N, Nakamura Y, Noguchi M, Leland P, Friedman MC, Miyajima A, Pun PK, Paul EM and Leonard WJ. (1993). Science, 262, 1880-1883.
27. Singh RK, Gutman M, Radinsky R, Bucana CD and Fielder IJ. (1994). Cancer Res., 54, 3242-3247.
28. Takeshita T, Ohtain K, Asao K, Kumaki S, Nakamura M and Sugamura K. (1992). J. Immunol., 148, 2154-2158.
29. Voss SD, Leary TP, Sondel PM, Robb RJ. (1993). Proc. Natl. Acad. Sci. USA, 90, 2428-2432.
30. Waldmann TA. (1993). Immunol. Today, 14, 264-270.
31. Weidman E, Sacchi M, Plaisance S, Heo DS, Yasamura S, Lin WC, Johnson JI, Hebermann RB, Azzarone B and Whiteside T. (1992). Cancer Res. 52, 5963-5970.